Jane Street
ADVM

Jane Street’s Adverum Biotechnologies ADVM Stock Holding History

Jane Street’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-70,931
Closed -$153K – 10669
2025
Q2 		$153K Buy
+70,931
New +$198K ﹤0.01% 8737
2024
Q3 		– Sell
-29,202
Closed -$200K – 9494
2024
Q2 		$200K Buy
+29,202
New +$272K ﹤0.01% 8383
2023
Q4 		– Sell
-3,388
Closed -$50.8K – 9118
2023
Q3 		$50.8K Sell
3,388
-1,275
-27% -$22.9K ﹤0.01% 8152
2023
Q2 		$74.1K Sell
4,663
-4,601
-50% -$48.4K ﹤0.01% 8110
2023
Q1 		$66.5K Buy
9,264
+2,348
+34% +$16.6K ﹤0.01% 8368
2022
Q4 		$40.1K Buy
6,916
+5,534
+400% +$42K ﹤0.01% 8435
2022
Q3 		$13K Buy
+1,382
New +$18.2K ﹤0.01% 9287
2022
Q1 		– Sell
-4,866
Closed -$86K – 10192
2021
Q4 		$86K Buy
4,866
+3,662
+304% +$73.3K ﹤0.01% 9317
2021
Q3 		$26K Buy
+1,204
New +$30.7K ﹤0.01% 9714
2021
Q2 		– Sell
-4,206
Closed -$227K – 9695
2021
Q1 		$415K Sell
4,206
-1,172
-22% -$141K ﹤0.01% 7122
2020
Q4 		$583K Sell
5,378
-2,023
-27% -$250K ﹤0.01% 5505
2020
Q3 		$762K Buy
7,401
+154
+2% +$23.1K ﹤0.01% 4516
2020
Q2 		$1.51M Buy
7,247
+5,663
+358% +$1M ﹤0.01% 3449
2020
Q1 		$155K Sell
1,584
-560
-26% -$65.3K ﹤0.01% 4765
2019
Q4 		$247K Sell
2,144
-1,929
-47% -$170K ﹤0.01% 4512
2019
Q3 		$222K Buy
+4,073
New +$459K ﹤0.01% 4531
2018
Q2 		– Sell
-1,011
Closed -$59K – 4898
2018
Q1 		$59K Buy
+1,011
New +$62.9K ﹤0.01% 4662
2017
Q4 		– Sell
-2,967
Closed -$108K – 4499
2017
Q3 		$108K Buy
+2,967
New +$82.3K ﹤0.01% 4257

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Jane Street's ADVM Position: Q3 2025 in Review

Jane Street sold out of Adverum Biotechnologies (ADVM) in Q3 2025, closing a stake of 70,931 shares — an estimated $153K sold.

Jane Street first reported a position in ADVM in Q3 2017 and held it in 18 quarters. The position peaked at $1.51M in Q2 2020. 50 funds tracked by Wall St. Rank hold ADVM as of Q3 2025.

  • Jane Street reported no remaining Adverum Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 70,931 Adverum Biotechnologies shares in Q3 2025, an estimated $153K.
  • Jane Street first reported a position in Adverum Biotechnologies in Q3 2017 and held it in 18 quarters.
  • Jane Street's Adverum Biotechnologies position peaked at $1.51M in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.